{"schema_version":"secwatch.filing_event.v1","accession":"0001604665-23-000004","form_type":"8-K","ticker":"WLKP","cik":"0001604665","company_name":"Westlake Chemical Partners LP","filed_at":"2023-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.801133+00:00","generated_at":"2026-06-19T06:57:47.607163+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Westlake Chemical Partners Q4 net income $16.8M, down 43% YoY; distribution held at $0.4714/unit","bullets":["Q4 2022 net income attributable to Partnership $16.8M ($0.48/unit) vs $29.5M in Q4 2021, down on lower buyer deficiency fee and higher interest expense.","Full year 2022 net income $64.2M ($1.82/unit) vs $82.5M in 2021, down on lower third-party sales margins and higher interest expense.","MLP distributable cash flow Q4 2022 $20.3M, up from $15.3M in Q4 2021; full year $75.9M vs $70.1M.","Declared Q4 distribution of $0.4714/unit, payable Feb 16, 2023; trailing twelve-month coverage ratio 1.14x (up from 1.07x).","CEO cites resilient cash flows from Westlake sales agreement despite high inflation and low ethylene margins."],"urls":{"canonical":"https://secwatch.observer/filing/0001604665-23-000004","json":"https://secwatch.observer/filing/0001604665-23-000004.json","markdown":"https://secwatch.observer/filing/0001604665-23-000004.md","text":"https://secwatch.observer/filing/0001604665-23-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604665/000160466523000004/0001604665-23-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604665/000160466523000004/wlkp-20230221.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T06:57:47.607163+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"609ebfbdeaf6901f93ff2467329a50c23189b1ab","claim":"Westlake Chemical Partners LP reported the fourth quarter of 2022 results: net income $16.8 million, EPS $0.48 per limited partner unit.","evidence_excerpt":"Westlake Chemical Partners LP (NYSE: WLKP) (the \"Partnership\") today reported net income attributable to the Partnership in the fourth quarter of 2022 of $16.8 million, or $0.48 per limited partner unit","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604665/000160466523000004/0001604665-23-000004-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter of 2022"},{"label":"Net income","value":"$16.8 million"},{"label":"EPS","value":"$0.48 per limited partner unit"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"b736f875b3b7b6ed3369df6abecca048173ac3cd","claim":"Westlake Chemical Partners LP reported the full year 2022 results: net income $64.2 million, EPS $1.82 per limited partner unit.","evidence_excerpt":"For the full year 2022, net income attributable to the Partnership of $64.2 million, or $1.82 per limited partner unit","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604665/000160466523000004/0001604665-23-000004-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year 2022"},{"label":"Net income","value":"$64.2 million"},{"label":"EPS","value":"$1.82 per limited partner unit"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}